Press

Press & Media

MyDeprescriber.com is a US directory of clinicians trained in evidence-based psychiatric deprescribing, and the certification program that trains them.

Media inquiries: press@mydeprescriber.com

What we are

MyDeprescriber.com, LLC is an independent Arizona company. We do two things: we publish free, referenced guides on coming off psychiatric medication safely, and we run The Deprescriber’s Playbook, a thirteen-module certification for clinicians in hyperbolic (proportional) tapering. Clinicians who complete the course and pass the final examination are listed as Certified Deprescribers in our public directory for 24 months.

We take no pharmaceutical funding and run no third-party advertising. Our revenue comes from clinician certification and premium directory listings, disclosed in our editorial policy.

The story we can speak to

Most prescribers were trained to stop antidepressants, benzodiazepines and Z-drugs over a matter of weeks. A growing body of evidence says that is too fast for many people, and that the withdrawal which follows is routinely misread as the original condition returning. The UK’s National Institute for Health and Care Excellence moved to proportional dose reductions in 2022; US guidance has not followed. We can speak to what that gap looks like from the patient side and from the prescriber side.

We are careful about what we claim. We do not promise clinical outcomes, and where the evidence is genuinely contested we say so.

Clinical lead

Lindsay Hill, DNP, PMHNP-BC — board-certified psychiatric mental health nurse practitioner, and the clinical author of MyDeprescriber’s patient and prescriber guides. Available for comment on psychiatric deprescribing, withdrawal versus relapse, and tapering method. Full bio on our About page.

Using our material

Journalists are welcome to quote our published guides with attribution to MyDeprescriber.com and a link to the page quoted. If you need a source checked or a claim clarified before publication, email us and we will get back to you quickly — we would much rather answer a question than see the science garbled.

Brand assets are available on request.

A note for anyone writing about withdrawal

If your piece may reach readers who are struggling: please include the US Suicide & Crisis Lifeline (call or text 988) and the SAMHSA National Helpline (1-800-662-4357), and please avoid framing that encourages readers to stop a psychiatric medication without clinical supervision. Stopping some of these medications abruptly can be dangerous.